SITC 2023 Comparison of Blinatumomab and Biosimilar CD19xCD3 BiTE responses in PBMC-Humanized Mice Used as a Preclinical Lymphoma Mouse Mode Published Date October 30, 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen